Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

4.60USD
14 Dec 2018
Change (% chg)

$-0.09 (-1.92%)
Prev Close
$4.69
Open
$4.66
Day's High
$4.70
Day's Low
$4.56
Volume
249,983
Avg. Vol
460,569
52-wk High
$9.41
52-wk Low
$4.24

Select another date:

Mon, Jul 30 2018

FDA approves Progenics' treatment for rare adrenal gland tumors

The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of rare adrenal gland tumors, making it the first drug approved in the United States for this use.

UPDATE 1-FDA approves Progenics' treatment for rare adrenal gland tumors

July 30 The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of rare adrenal gland tumors, making it the first drug approved in the United States for this use.

FDA approves Progenics' treatment for two rare tumors

July 30 The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of tumors.

Select another date: